President Trump Targets $150 Price for GLP-1 Drugs, Impacting Eli Lilly and Novo Nordisk Stocks
Rapid Read Rapid Read

President Trump Targets $150 Price for GLP-1 Drugs, Impacting Eli Lilly and Novo Nordisk Stocks

President Trump announced his administration's goal to reduce the cost of GLP-1 weight loss drugs to $150 per month, significantly lower than their...
Summarized by AI
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.